Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor-related protein complex 5 subunit sigma-1 (AP5S1) is the small subunit of the AP-5 adaptor protein complex, one of five known adaptor protein complexes (AP-1 through AP-5) involved in mediating intracellular membrane trafficking. The AP-5 complex facilitates sorting and transport of cargo proteins within vesicles, particularly in late endosomal compartments[1][2]. AP5S1 does not act as a classical therapeutic target such as a receptor, enzyme, or channel, but is instead a structural and functional protein component of the AP-5 complex. Variants in AP5S1 have not been associated with human disease, but mutations in other AP-5 complex subunits and associated proteins (e.g., AP5Z1, SPG11, ZFYVE26) have been implicated in hereditary spastic paraplegia subtypes[2]. No drugs are currently known to interact with AP5S1, nor is it reported as a biomarker or safety risk.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor-related protein complex 5 subunit sigma-1 (AP5S1).